Notifications
Back
Notification settings
Back
More
Post notifications
Post reactions
Be notified when someone leaves a comment or a reply to your post or comment.
Updates and news
Stay ahead of important updates and news from the site.
Alarm
My account
Sign out
About us
Mission
People
Contact
Science
Overview
Platform
Publication
Patent
Program
Overview
First Program
Second Program
Manufacturing
CSO
What is CSO?
Why Choose CSO?
Inquiry
News
Notice
Press Release
Close
About us
Science
Program
CSO
News
Site logo
About us
Mission
People
Contact
Science
Overview
Platform
Publication
Patent
Program
Overview
First Program
Second Program
Manufacturing
CSO
What is CSO?
Why Choose CSO?
Inquiry
News
Notice
Press Release
MENU
About us
Mission
People
Contact
Science
Overview
Platform
Publication
Patent
Program
Overview
First Program
Second Program
Manufacturing
CSO
What is CSO?
Why Choose CSO?
Inquiry
News
Notice
Press Release
icon
Site logo
About us
Mission
People
Contact
Science
Overview
Platform
Publication
Patent
Program
Overview
First Program
Second Program
Manufacturing
CSO
What is CSO?
Why Choose CSO?
Inquiry
News
Notice
Press Release
MENU
About us
Mission
People
Contact
Science
Overview
Platform
Publication
Patent
Program
Overview
First Program
Second Program
Manufacturing
CSO
What is CSO?
Why Choose CSO?
Inquiry
News
Notice
Press Release
icon
MENU
Site logo
icon
NEWS
Press Release
Notice
Press Release
Notice
Press Release
Updates and news
NEWS
Dr. In-San Kim, a co-founder of SHIFTBIO INC., has been invited as a speaker to the ANSEV 2023 Conference
N
0
0
1 day(s) ago
Views
2
Updates and news
NEWS
Dr. Gi-Hoon Nam joined as a speaker at two of the largest startup events in the country
0
0
17 Nov 2023
Views
37
Updates and news
NEWS
SHIFTBIO INC is thrilled to join the Seoul-Basel Start-up program this November!
0
0
18 Oct 2023
Views
95
Updates and news
NEWS
Dr. Gi-Hoon Nam, CEO of SHIFTBIO: Invited as a speaker at the '2023 Biopharma Open Innovation'.
0
0
5 Oct 2023
Views
109
Updates and news
NEWS
Dr. Gi-Hoon Nam joined as a speaker at 'The 24th World Knowledge Forum'
0
0
22 Sep 2023
Views
135
Updates and news
NEWS
Dr. Gi-Hoon Nam, CEO of SHIFTBIO: Joined two consecutive years as speaker at 'The 5th Exosome Based Therapeutic Development Summit' in Boston
0
0
14 Sep 2023
Views
170
Updates and news
NEWS
[Triumphant Success at Korea Conference] A Star Wars of Startups
0
0
22 Aug 2023
Views
226
Updates and news
NEWS
SHIFTBIO INC. has initiated a joint research collaboration with the global enterprise Dassault Systems on an “AI-driven Cell-Free Nanotherapy Platform Technology.”
0
0
30 Jun 2023
Views
752
Updates and news
NEWS
SHIFTBIO INC. has been chosen to join President Yoon Suk-yeol's business delegation to the United States
0
0
20 Apr 2023
Views
206
Updates and news
NEWS
'2023 Hongneung Innovative Bio Forum'
0
0
31 Jan 2023
Views
383
Updates and news
NEWS
Happy New Year from SHIFTBIO
0
0
29 Dec 2022
Views
355
Updates and news
NEWS
"The communication tools between cells can be used as therapeutics."
0
0
27 Dec 2022
Views
318
Updates and news
NEWS
Congratulations on the second foundation anniversary of SHIFTBIO INC.
0
0
11 Nov 2022
Views
420
Updates and news
NEWS
Dr. In-San Kim, a co-founder of SHIFTBIO INC., has been appointed as a fellow researcher at the Korea Institute of Science and Technology (KIST)
0
0
4 Nov 2022
Views
663
Updates and news
NEWS
"Why to use EVs as the CD47 blockade?"
0
0
27 Oct 2022
Views
364
Updates and news
NEWS
SHIFTBIO INC announced the detailed realization plan upon The SBI-102 and the Intrinsic Nanovesicle-based platform technology
0
0
20 Oct 2022
Views
538
Updates and news
NEWS
SHIFTBIO INC and RoosterBio had a valuable discussion on the large-scale production process development of SHIFTBIO INC’s main pipeline, SBI-102, along with innovative business models
0
0
11 Oct 2022
Views
451
Updates and news
NEWS
Dr. Gi-Hoon Nam, Co-Founder of SHIFTBIO INC, has joined as a panelist at the 23rd World Knowledge Forum
0
0
26 Sep 2022
Views
458
Updates and news
NEWS
“SHIFTBIO, a company that puts the armor on the avatar of cells”
0
0
19 Aug 2022
Views
608
Updates and news
NEWS
SHIFTBIO INC. attended the GLOBAL INVESTMENT SUMMIT 2022
0
0
11 Jul 2022
Views
669
Updates and news
NEWS
Korea’s leading media group, JoongAng News interviewed SHIFTBIO
0
0
6 Jul 2022
Views
564
Updates and news
NEWS
Thomas M. Roberts and Kenneth W. Witwer became the first two official ShiftBio Scientific Advisory Board members!
0
0
20 Jun 2022
Views
798
Updates and news
ShiftBio Co., Ltd. Selected as 2022 'First Penguin' by KODIT
0
0
3 Jun 2022
Views
578
Updates and news
NEWS
ShiftBio Partners with RoosterBio Inc. to Develop SBI-102 for Rare Diseases and Cancer
0
0
27 Apr 2022
Views
841
Updates and news
ShiftBio presented at the 2022 Korea Conference in Los Angeles, USA!
0
0
30 Mar 2022
Views
785
Updates and news
NEWS
In-San Kim, MD, Ph.D. featured on the International Society for Extracellular Vesicles (ISEV) eNEWs
0
0
16 Mar 2022
Views
616
Updates and news
ShiftBio sponsored and hosted the EVs and EVs-based Therapeutics Online Conference, Seoul!
0
0
7 Mar 2022
Views
705
Previous
1
2
Next